Literature DB >> 20351215

New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.

Yongjung Park1, Jong-Han Lee, Beom Seok Kim, Do Young Kim, Kwang-Hyub Han, Hyon-Suk Kim.   

Abstract

An automated hepatitis C virus (HCV) antigen (Ag) assay was evaluated with clinical samples. Determination of HCV Ag and RNA levels in 282 subjects using Abbott HCV Ag and Roche Cobas TaqMan assays revealed that these two tests were highly correlated (r = 0.9464). Thus, the HCV Ag assay could be an alternative test to quantitative reverse transcription-PCR.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20351215      PMCID： PMC2884480          DOI： 10.1128/JCM.01856-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.

Authors:  Catherine Gaudy; Catherine Thevenas; Jean Tichet; Nicole Mariotte; Alain Goudeau; Frédéric Dubois
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Authors:  Syria Laperche; Nadine Le Marrec; Annie Girault; Françoise Bouchardeau; Annabelle Servant-Delmas; Michèle Maniez-Montreuil; Pierre Gallian; Thierry Levayer; Pascal Morel; Nicole Simon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population.

Authors:  K Hayashi; S Hasuike; K Kusumoto; A Ido; H Uto; N Kenji; M Kohara; S O Stuver; H Tsubouchi
Journal:  J Viral Hepat       Date:  2005-01       Impact factor: 3.728

4.  Dynamics of viremia in early hepatitis C virus infection.

Authors:  Simone A Glynn; David J Wright; Steven H Kleinman; Dale Hirschkorn; Yongling Tu; Charles Heldebrant; Richard Smith; Cristina Giachetti; James Gallarda; Michael P Busch
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

5.  Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen.

Authors:  K Aoyagi; C Ohue; K Iida; T Kimura; E Tanaka; K Kiyosawa; S Yagi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.

Authors:  Masahiko Takahashi; Hidetsugu Saito; Makiko Higashimoto; Kazuhiro Atsukawa; Hiromasa Ishii
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Performance of hepatitis C virus core antigen immunoassay in monitoring viral load after liver transplantation.

Authors:  Anna Massaguer; Xavier Forns; Josep Costa; Anna Feliu; Montserrat García-Retortillo; Miquel Navasa; Antoni Rimola; Juan Carlos García-Valdecasas; José Maria Sánchez-Tapias
Journal:  Transplantation       Date:  2005-05-27       Impact factor: 4.939

8.  Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.

Authors:  Masaru Enomoto; Shuhei Nishiguchi; Akihiro Tamori; Modoka Kohmoto; Daiki Habu; Hiroki Sakaguchi; Tadashi Takeda; Norifumi Kawada; Shuichi Seki; Susumu Shiomi
Journal:  J Med Virol       Date:  2005-09       Impact factor: 2.327

9.  Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy.

Authors:  Roberta Soffredini; Maria Grazia Rumi; Maria Luisa Parravicini; Guido Ronchi; Ersilio Del Ninno; Antonio Russo; Massimo Colombo
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

10.  Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

Authors:  C Niederau; S Lange; T Heintges; A Erhardt; M Buschkamp; D Hürter; M Nawrocki; L Kruska; F Hensel; W Petry; D Häussinger
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425
View more
  29 in total

1.  Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients.

Authors:  V Descamps; A Op de Beeck; C Plassart; E Brochot; C François; F Helle; M Adler; N Bourgeois; D Degré; G Duverlie; S Castelain
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 2.  New virologic tools for management of chronic hepatitis B and C.

Authors:  Stéphane Chevaliez; Christophe Rodriguez; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Comparison of HCV core antigen and anti-HCV with HCV RNA results.

Authors:  Cicioğlu Arıdoğan Buket; Aynali Ayşe; Kaya Selçuk; Önal Süleyman; Sesli Çetin Emel
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

4.  Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Authors:  Recep Kesli; Hakki Polat; Yuksel Terzi; Muhammet Guzel Kurtoglu; Yavuz Uyar
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

Review 5.  Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.

Authors:  Carolina V Uliana; Carla S Riccardi; Hideko Yamanaka
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

6.  Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection.

Authors:  A Alsiö; A Jannesson; N Langeland; C Pedersen; M Färkkilä; M R Buhl; K Mørch; J Westin; K Hellstrand; G Norkrans; M Lagging
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-24       Impact factor: 3.267

Review 7.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  A rapid, low-cost quantitative diagnostic method for hepatitis C virus infection using capillary zone electrophoresis.

Authors:  A M Attallah; S O Abdallah; M A El-Desouky; M El-Far; M M Omran; K Farid; M A Abdelrazek; M N Shabaka; H Zaghloul; A M Fawzy; F B Bazeed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-20       Impact factor: 3.267

9.  Is hepatitis C virus core antigen an adequate marker for community screening?

Authors:  Yuan-Hung Kuo; Kuo-Chin Chang; Jing-Houng Wang; Pei-Shan Tsai; Shu-Feng Hung; Chao-Hung Hung; Chien-Hung Chen; Sheng-Nan Lu
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

10.  Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria.

Authors:  Ogbodo Ekene Newton; Otue Akpevwe Oghene; Iheanyi Omezuruike Okonko
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.